Juvenile Scleroderma Progression Similar To Adult Onset PDF Print E-mail
Friday, 27 July 2012 16:12
The pattern and course of disease in patients who develop systemic sclerosis in childhood or adolescence is similar to that in patients who develop the disease as adults, data from Europe has shown.

There were 60 patients among 5,000 included in the EUSTAR database (1.2%) who developed systemic sclerosis before the age of 16. Their mean age of onset was 12.4 years. They were compared with another 910 patients who first developed symptoms between the ages of 20 and 40, at a mean of 32 years.

Both groups had a mean disease duration of 17 years, and the illness was active at the last follow-up in about one-quarter of cases. The distribution of disease subsets was similar in juvenile-onset and adult-onset cases: roughly 40% had diffuse disease, 50% had limited disease and 10% had overlap syndrome.

There were no significant differences between the two groups in the extent of organ involvement. Raynaud’s phenomenon was most common, affecting 95%, followed by oesophageal involvement (60-65%), digital ulcers (35-41%), joint contractures (30-37%) and pulmonary fibrosis (23-36%). Antibody profiles were also similar, except that the frequency of anti-centromere antibodies was higher in the juvenile-onset cohort.

In 15 of the 60 juvenile-onset patients, the first non-Raynaud’s symptoms emerged before the age of 10 years. Compared to post-pubertal onset, pre-pubertal onset was associated with a higher proportion of male cases and a higher modified Rodnan skin score. “Juvenile systemic sclerosis is a rare disease in childhood, with an estimated incidence of 0.5 per 100,000 and a prevalence of about 1 in 1,000,000,” the researchers said.

“It has been hypothesised that about 10% of all patients develop the disease before the age of 16 years but nothing is known about whether puberty has any influence on the incidence.”

Source: James, T. (2012), "Juvenile-onset systemic sclerosis resembles adult-onset disease"; Rheumatology Update; Original article can be viewed here.

 
More articles :

» Ryan Roy Racing to Raise Awareness of Scleroderma

Ryan Roy, of Bellingham, Wash., only has been doing triathlons for two years. In 2010, he completed three races at sprint and Olympic distances. For 2011, in addition to competing in sprint and Olympic triathlons, and his first half marathon in...

» Types of Stem Cell Treatments for Scleroderma

is a slowly debilitating terminal illness that robs the skin, limbs and vital organs through the process of pain upon exposure to cold and the tightening, thickening and in-elasticity of the skin. Scleroderma deposits connective tissue in places...

» A New Marker of Silent Cardiovascular Disease in Diffuse Scleroderma

Patients with diffuse systemic sclerosis (SSc) and no clinical evidence of (CVD) may, in fact, have subclinical CVD and , and it is detectable. This is the conclusion of a small pilot study from Italy, which showed that elevated plasma levels of ...

» Curcumin May Have Therapeutic Value In Treating Scleroderma

Turmeric, a shrub related to ginger, is grown throughout India, other parts of Asia, and Africa. It is well known for its warm, bitter taste and golden yellow color. Turmeric is commonly used in fabric dyes and foods such as curry powders, mustards,...

» UT Researchers At Forefront Of Efforts To Stem The Tide Of Autoimmune Diseases

Autoimmune and autoinflammatory diseases are on the rise and researchers and physicians at are at the forefront of efforts to stem the tide. These diseases are often hard to diagnose and often affect individuals differently.Autoimmune and...

» What Are The Odds Of Having A Rare Disease?

There are over 7,000 known rare disorders or diseases, a statistic which is continually growing as medical science advances. The European Union's definition of a rare disorder or disease is a condition which affects 5 or less people in every 10,000....